Stem cells = gene therapy?

A Stanford bioethicist compares the possible hazards of stem cells with the challenges gene therapy faced a decade ago.

I don’t feel I have enough experience with university IRBs to judge whether stem cells need more regulatory oversight. Before reading this, I didn’t realize the FDA had placed a hold on the first clinical trial using a ES-cell-derived product. I aim to pay closer attention to this issue.

The clinical trial in question would deal with spinal cord injury. It appears that experts in cardiac muscle repair also disagree over whether enough is known about how stem cells work in that arena.

Advertisements

2 Comments »

  1. Alexey said

    yes, regulation organizations are alarmed about ES clinical trials, because of troubles with gene therapy trials

    it’s actually second time when FDA suspended ES-based clinical trial – 1st with Stem Cells, 2nd with Geron

  2. IAN Trevan said

    Do we have new issues about stomatological stem cell terapy?What is its advance?Please,write me the news about that.Thank you.

RSS feed for comments on this post · TrackBack URI

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: